Osaka, Japan

Yasuhiro Menjo

USPTO Granted Patents = 14 


 

Average Co-Inventor Count = 10.9

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Tokushima, JP (2011 - 2018)
  • Osaka, JP (2012 - 2023)

Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Yasuhiro Menjo: Innovator in Benzazepine Derivatives

Introduction

Yasuhiro Menjo is a prominent inventor based in Osaka, Japan, known for his significant contributions to the field of medicinal chemistry. With a total of 14 patents to his name, he has made remarkable advancements in the development of novel compounds.

Latest Patents

One of Menjo's latest patents focuses on benzazepine derivatives. The invention provides novel benzazepine compounds of Formula (1), or salts thereof, which exhibit vasopressin V and V antagonisms, along with their medical uses. The formula includes various components, where R is optionally substituted Calkyl, L is —C(=O)—NH—, and Ring A is a hydrocarbon ring. Each of Rings A and A may have at least one substituent, showcasing the complexity and potential of these compounds in therapeutic applications.

Career Highlights

Throughout his career, Yasuhiro Menjo has worked with notable companies, including Otsuka Pharmaceutical Company, Limited and I. Otsuka Pharmaceutical Co., Ltd. His work in these organizations has allowed him to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Menjo has collaborated with esteemed colleagues such as Takahiro Tomoyasu and Shin Miyamura, further enhancing the innovative environment in which he operates.

Conclusion

Yasuhiro Menjo's work in the field of benzazepine derivatives exemplifies his dedication to advancing medicinal chemistry. His numerous patents and collaborations highlight his impact on the industry and his commitment to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…